Intuitive Surgical (NASDAQ: ISRG) reported Q3 EPS of $2.40, $0.41 better than the analyst estimate of $1.99. Revenue for the quarter came in at $2.51 billion versus the consensus estimate of $2.41 billion.

2025 Financial Outlook

The Company expects the following results for the full year of 2025:

• Worldwide da Vinci procedure growth of approximately 17% to 17.5% in 2025, compared to 17% in 2024.
• Non-GAAP* gross profit margin to be within a range of 67% and 67.5% of revenue in 2025, compared to 69.1% in 2024. This range includes an estimated impact from tariffs of 0.7% of revenue, plus or minus 10 basis points.
• Non-GAAP* operating expense growth of 11% to 13% in 2025, compared to 10% in 2024.
• For earnings history and earnings-related data on Intuitive Surgical (ISRG) click here.